Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hinge Health (HNGE) Shares Outstanding (Diluted Average) (2023 - 2025)

Hinge Health's Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $54.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 302.54% year-over-year to $54.6 million; the TTM value through Dec 2025 reached $54.6 million, up 302.54%, while the annual FY2025 figure was $54.6 million, 302.54% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $54.6 million at Hinge Health, up from $46.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $54.6 million in Q4 2025 and bottomed at $13.0 million in Q4 2023.
  • The 3-year median for Shares Outstanding (Diluted Average) is $13.6 million (2024), against an average of $28.2 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) grew 4.16% in 2024 before it soared 302.54% in 2025.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $13.0 million in 2023, then grew by 4.16% to $13.6 million in 2024, then skyrocketed by 302.54% to $54.6 million in 2025.
  • Per Business Quant, the three most recent readings for HNGE's Shares Outstanding (Diluted Average) are $54.6 million (Q4 2025), $46.2 million (Q3 2025), and $13.6 million (Q4 2024).